glp-1 trial results today Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Major Advancement in Obesity Treatment:
Description
Commun Med
doi: 10.1074/jbc.M206006200
But there are weight and health requirements, and those who already get GLP-1s covered for diseases like diabetes and sleep apnea won't qualify
The antioxidant action of GLP-1 is mediated by the activation of the cyclic AMP (cAMP) - protein kinase A (PKA) pathway, which downregulates the activity of Nox4 (82, 83)
